- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top pharmaceutical companies by SG&A to revenue rate 2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Top pharmaceutical companies by SG&A to revenue rate 2017
SG&A to revenue rate of top pharmaceutical companies in 2017*
This statistic shows the SG&A to revenue rate of global top pharmaceutical companies in 2017. With around 55 percent, Regeneron had one of the highest rates among top pharmaceutical companies that year. Growth of selling, general, and administrative expenses should not exceed sales growth because it would cut a company's profitability.
SG&A to revenue rate of top pharmaceutical companies in 2017*
| SG&A to revenue | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| SG&A to revenue | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the SG&A to revenue rate of global top pharmaceutical companies in 2017. With around 55 percent, Regeneron had one of the highest rates among top pharmaceutical companies that year. Growth of selling, general, and administrative expenses should not exceed sales growth because it would cut a company's profitability.
Show more- Show sources information
- Show publisher information
- Release date
- September 2018
- Region
- Worldwide
- Survey time period
- 2017
- Supplementary notes
- * SG&A = Selling, General and Administrative Expenses. Also known as the fixed day to day costs of a company. Spending on marketing is also included.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- September 2018
More information
- Region
- Worldwide
- Survey time period
- 2017
- Supplementary notes
- * SG&A = Selling, General and Administrative Expenses. Also known as the fixed day to day costs of a company. Spending on marketing is also included.
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Novartis"
- Global positioning
The most important statistics
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2018
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Top 20 pharmaceutical companies based on R&D spending as revenue share in 2017 and 2024*R&D spending share of top pharmaceutical companies 2017 and 2024
- Net profit per employee of global top pharmaceutical companies in 2017 (in 1,000 U.S. dollars)Net profit generated per employee in top pharmaceutical companies 2017
- Company overview
The most important statistics
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's net income from 2007 to 2018 (in billion U.S. dollars)Novartis' net income 2007-2018
- Dividends paid by Novartis AG from 2009 to 2018 (in billion U.S. dollars)Dividends paid by Novartis AG 2009-2018
- Total number of Novartis AG's full-time employees from 2009 to 2018*Novartis' number of full-time employees 2009-2018
- Revenue distribution
The most important statistics
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Novartis AG's revenue from 2016 to 2018, by region (in million U.S. dollars)Novartis' revenue by region 2016-2018
- Percentage of Novartis AG's revenue in 2018, by segment and market*Novartis - revenue 2018 by segment and market
- Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2018*Percentage of Novartis pharmaceuticals revenue by therapy area 2018
- Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)Novartis' top drugs based on revenue 2018
- Research and development
The most important statistics
- Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)Novartis' expenditure on research and development 2004-2018
- Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2018Novartis' R&D expenditure as a percent of revenue 2004-2018
- Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)Novartis' spending on research and development by division 2017-2018
- Miscellaneous
The most important statistics
- Patients reached by products of Novartis AG from 2009 to 2018 (in millions)Patients reached by Novartis AG's products 2009-2018
- Novartis advertising spending in the United States from 2012 to 2017 (in million U.S. dollars)Novartis: ad spend in the U.S. 2012-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Revenue shares of big pharma as of 2017, by business strategy
- Pharmaceutical companies by highest net margin 2014
- Leading global pharmaceutical risers based on share price 2018
- Leading global pharmaceutical risers based on market capitalization 2018
- Rebates/discounts by select companies as share of US pharma sales 2009-2013
- Top ten pharmaceutical merger and acquisition deals by value 2014
- Total value of top pharmaceutical venture financing deals 2014
- Importance of digital health strategy objectives for pharma companies 2013
- Leading pharmaceutical companies in Sweden 2017, by turnover
- Digital health strategy priorities for pharma companies 2013
- Profit margin of top global pharmaceutical companies 2013
- Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024
- Top companies developing medicines for children in developing countries 2014
- Value of top 10 yet to close pharmaceutical deals Q1 2017
Studies
- Pharmaceutical trends in Europe
- Pharmaceutical industry in Italy
- Indicatori Farmaceutici
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in the Netherlands
- Teva - 2018 Form 10-K
- Generic Pharmaceutical Industry Yearbook 2016
- Novo Nordisk ANNUAL REPORT 2017
- Great Expectations: Why Pharma Companies Can’t Ignore Patient Services
- Biotechnology in Germany
- 2018 PhRMA Annual Membership Survey
- Boehringer Ingelheim - Annual Report 2017
- Life Sciences Outlook United States 2017
Statistics on "Novartis"
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2018 (in billion U.S. dollars)
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Top 20 pharmaceutical companies based on R&D spending as revenue share in 2017 and 2024*
- Net profit per employee of global top pharmaceutical companies in 2017 (in 1,000 U.S. dollars)
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
- Novartis AG's net income from 2007 to 2018 (in billion U.S. dollars)
- Dividends paid by Novartis AG from 2009 to 2018 (in billion U.S. dollars)
- Total number of Novartis AG's full-time employees from 2009 to 2018*
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)
- Novartis AG's revenue from 2016 to 2018, by region (in million U.S. dollars)
- Percentage of Novartis AG's revenue in 2018, by segment and market*
- Percentage of Novartis AG's pharmaceuticals revenue by therapy area in 2018*
- Novartis AG's top 10 drugs based on revenue in 2018 (in million U.S. dollars)
- Novartis AG's expenditure on research and development from 2004 to 2018 (in billion U.S. dollars)
- Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2018
- Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)
- Patients reached by products of Novartis AG from 2009 to 2018 (in millions)
- Novartis advertising spending in the United States from 2012 to 2017 (in million U.S. dollars)
- Revenue distribution of focused and diversified big pharma companies as of 2017
- Global top pharmaceutical companies based on net income margin in 2014*
- Top 3 big pharma companies based on growth of share price in 2018
- Top 3 big pharma companies based on market capitalization growth in 2018 (in billion U.S. dollars)*
- Rebates and discounts by selected companies as share of their U.S. pharmaceutical sales from 2009 to 2013
- Top 10 pharmaceutical merger and acquisition deals worldwide by value in 2014 (in billion U.S. dollars)*
- Top 10 venture financing deals in worldwide pharmaceutical industry by value in 2014 (in million U.S. dollars)*
- Importance of digital health strategy objectives for pharmaceutical companies in 2013
- Leading pharmaceutical companies in Sweden in 2017, by turnover (in 1,000 SEK)
- Digital health strategy priorities for pharmaceutical companies as of 2013
- Profit margin of top 10 global pharmaceutical companies in 2013
- Top 10 pharmaceutical companies based on global anti-viral revenue in 2017 and 2024 (in million U.S. dollars)
- Number of medicines for children being developed by pharmaceutical companies in developing countries as of 2014
- Top 10 yet-to-close pharmaceutical deals worldwide based on value announced in the first quarter of 2017 (in billion U.S. dollars)*
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.